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Doping: a rising public health problem, 
but no attention to supply yet  
• Doping products: substances and methods banned by WADA  
• Used by athletes and sportspeople to enhance performance  
• Increasingly also used outside sports to enhance non-sport 
performances, image or aggressiveness 
– Lifetime prevalence of steroid use estimated in at least 3% in young men 
worldwide (Kanayama et al. 2009) 
• Comparable to prevalence of some illegal drugs 
• Numerous studies on demand, hardly on supply 
 
 How is the market organized? Who are the suppliers?  
What are their motivations, modus operandi revenues and profits? 
Anti-doping system: 
from athletes’ testing to law enforcement 
• Anti-doping system has traditionally focused on elite 
athletes, with testing as primary control measure 
• Testing is increasingly seen as ineffective and costly 
– Only about 1% of athletes tests positive 
• Sports governing bodies increasingly see criminal law 
enforcement as attractive option 
– For WADA President Fahey, law enforcement is “future of anti-doping” 
• Wide differences in state policies concerning possession 
of, and trade in, doping products 
– A few countries, in primis Italy, have criminalized trade in doping 
products and actively prosecute suppliers 
 
 
What can anti-doping criminal law enforcement achieve? 
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WADA-funded study 
with two main aims:  
• On the basis of Italy’s anti-
doping criminal law 
experience  
1. To analyze production and 
distribution (supply) of doping 
products 
2. To understand how anti-
doping criminal provisions  
and their enforcement can 
contribute to improve control 
of doping  
Research design 
• Thanks to intense collaboration with Comando Carabinieri per la 
Tutela della Salute (NAS), we drew on multiple data sources, 
largely from criminal justice system 
– Official documents of 46 anti-doping investigations 
– 80 data files on major NAS investigations from 1999 to 2009 
– Data on anti-doping activities of all 38 NAS Branch Offices 
– Seizure data from all police forces 
– Interviews with 26 NAS officers 
– Interviews with 7 prosecutors and 2 other experts 
– All relevant statistics 
– Scientific and grey literature and media    
• Triangulated data to validate findings 
Doping is conceived as semi-legal market 
• Market approach is new in case of doping 
• Legal status of doping products suffers the burden and 
ambiguity of contextual specificity 
• Legal status of supply-side activities varies depending on 
legislation in different countries  and, even within each 
country, depending on  
– Products exchanged and their final use 
– Bona fide of some suppliers (e.g., pharmacists) 
– Applicable offences  
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A large market, a public health issue 
Users  
of doping products 
Percent  
of total 
Users w/o cannabis 
or cocaine 
Percent  
of total 
Athletes  185,000 73% 150,000 69% 
Body-builders 68,700 27% 68,700 31% 
Total 253,700 100% 218,700 100% 
• Estimate is very conservative:  
̶ Based on CVD’s positive results and investigation results for body-builders 
̶ No estimate for non-competitive sports-persons and physically inactive people 
• Roughly same amount of people consume doping products as heroin 
• CONI’s super-elite athletes (10,000) represent tiny minority (3.9%) 
CONI v. CVD 
  2002 2003 2004 2005 2007 Average 
Total tests  7,823 9,431 9,950 8,791 11,154 9,430 
Positive results 48 62 65 52 69 59 
Percent of 
positive results 
0.61 0.66 0.65 0.59 0.62 0.63 
Anti-doping-tests carried out by the Italian National Olympic Committee (CONI)   
and sports federations on elite athletes – 2002-07 
  
2003 2004 2005 2006 2007 2008 2009 2010 2011 
Average 
2008-11 
Total tests  740 1,556 1,875 1,511 1,607 955 1,328 1,115 1,676 
1,374 
Positive results 20 42 37 37 46 39 42 53 52 
46.5          
Percent of 
positive results  
2.7 2.7 2.0 2.4 2.9 4.1 3.2 4.8 3.1 3.8 
Anti-doping-tests carried out by Commissione per la vigilanza e il controllo sul doping e per la 
tutela della salute nelle attività sportive (CVD) on recreational athletes – 2003-11  
Source: CONI, 2012. 
Source: 
Ministero 
della Salute 
and ISS; 
several 
years. 
NB: CONI has published no data about positive results since 2007; it published in late 2012 data on adverse results. 
Doping doses for the main types  
of doping substances seized by NAS 
Doping substances 1 dose 
Anabolic agents 10 mg 
Peptide hormones, growth factors and related 
substances, of which 
  
-  EPO and other similar peptide hormones  200 IU or 1 mcg 
-  GH and other similar peptide hormones 1 IU or 0.333 mg 
-  Chorionic gonadotrophin 1,000 IU 
-  Gonadorelin 1.2 mg 
-  Adrenocorticotrophic hormone (ACTH)  
and other  corticotrophins 
0.25 mg 
- Insulin 10 IU 
Beta-2 agonists 2 mcg 
Hormones and metabolic modulators 10 mg 
Diuretics and other masking agents 25 mg 
Stimulants 25 mg 
Narcotics  50 mg 
Glucocorticosteroids 25 mg 
Beta-blockers 5 mg 
88 m doses seized by NAS in 1999-2009 
Type of substance 
Pills, ampoules 
and other 
packages seized  
Active ingredients 
seized (mg) No. of 
doping doses 
% of total 
doses 
Anabolic agents 3,531,232 745,476,230 74,547,623 83.16% 
Peptide hormones, growth factors and 
related substances, of which:   
45,812 Not comparable 1,604,608 1.79% 
-EPO and similar hormones 12,430 Not comparable 626,335 0.70% 
-GH and other growth factors 20,482 Not comparable 928,335 1.04% 
-Related substances* 12,900 Not comparable 49,938 0.06% 
Beta-2 agonists 640 9,780 4,890 0.01% 
Hormones and metabolic modulators 35,561 355,610  35,561 0.04% 
Diuretics and other masking agents 13,339 340,125 13,605 0.02% 
Stimulants 3,373,570 291,379,175 11,655,167 13.00% 
Narcotics  1 6,750 135 0.00% 
Glucocorticosteroids 130,802 4,549,125 181,965 0.20% 
Beta-blockers 11 55 11 0.00% 
TOTAL 7,176,780 1,042,116,850 88,043,565 100.00% 
Source: our 
elaboration 
on NAS 
data. 
Steroids and body-builders account  
for lion’s share of market 
Substances Athletes Body-builders 
Total doses  
per class 
Percent of 
total 
Anabolic agents    45,304,348 173,522,903 218,827,251  58.93% 
Peptide  hormones, growth factors 
and related substances*, of which 
   19,956,522  3,767,419    23,723,941  6.39% 
- EPO 7,675,907 0 7,675,907 2,07% 
- GH** n.a. 3,564,001 3,767,419 0,96% 
- Chorionic Gonadotropin 12,280,615 203,418 12,484,033 3,36% 
Beta-2 agonists 13,130,435 11,081 13,141,515 3.54% 
Hormones and metabolic modulators 0 132,968 132,968 0.04% 
Diuretics and other masking agents 32,391,304 55,403 32,446,708  8.74% 
Stimulants 24,739,130 27,036,774 51,775,905  13.94% 
Narcotics       7,000,000  0       7,000,000 1.89% 
Glucocorticosteroids    21,130,435 531,871    21,662,306 5.83% 
Beta-blockers     2,608,696  0     2,608,696  0.70% 
Total doses 166,260,870  205,058,419  371,319,290    
Percent of total 44.78% 55.22% 100.0%   
Key 
substances 
are excluded  
for which 
there are 
clues of 
misuse: e.g., 
gonadorelin  
Region/Province Packages sold Total value 
 Packages sold 
per 100,000  
Total value 
per 100,000 
Piedmont 28,178 7,342,211 635.7 165,642 
- Novara province 4,063  1,113,759  1,184.4 324,673 
Aosta Valley 28 8,106 22.0 6,379 
Trentino Alto Adige 97 26,557 9.5 2,607 
Venetium 5,675 1,661,377 116.2 34,006 
Friuli 1,645 507,734 133.6 41,248 
Liguria 814 235,196 50.4 14,563 
Emilia Romagna 2,942 758,387 67.8 17,482 
- Ferrara province 2,396 623,474 669.3 174,164 
Tuscany 851 203,713 23.0 5,494 
Umbria 12 1,576 1.3 176 
Marche 867 242,723 55.2 15,464 
Latium 872 233,825 15.5 4,156 
Abruzzo 42 5,211 3.1 390 
Molise 401 147,955 125.0 46,121 
Campania   12,311        2,921,818  211.8 50,268 
- Salerno Province 6,207 1,508,804 561.2 136,408 
Apulia 157 35,247 3.4 864 
Basilicata 270 89,674 45.7 15,184 
Calabria 15,317 4,297,389 762.5 213,938 
- Cosenza province 7,049 2,024,430 961.0 275,993 
Sicilia 8,542 2,266,027 169.6 44,980 
- Caltanissetta province 2,583 748,339 948.6 274,833 
- Palermo province 5,406 1,393,428 434.3 111,951 
Sardegna 431 78,859 25.8 4,719 
Total 101,310 26,727,207 168.7 44,512 
Selected provinces and 
region 
            35,972 
(35.5%)  
  9,685,193 
(36.2%)  
674.5 181,616 
Rest of country            65,338  17,042,014  119.4 31,148 
Hypothetical sales in 
selected provinces and 
region at average rate 
  11,564    1,661,081 119.4 31,148 
Difference effective and 
hypothetical sales 
        24,408 
(24.1%)  
8,024,112 
(30.0%)  
n.a. n.a. 
Source: CVD, 2010 and Istat, for 
the population data. 
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Suppliers are NOT marginalized 
• Mostly men 
• Mostly Italian 
• Few have criminal records for doping-related offences or 
fights 
– Hardly anybody has traditional criminal career 
• Most of them have legitimate profession or occupation 
 
 
Most suppliers are white-collar criminals 
Category Type 
Gym 
Gym managers or owners and body-building instructors  
Managers or owners of dietary supplement shops 
Health care 
Pharmacists 
Physicians 
Hospital, health clinic and nursing home employees 
Employees or salesmen of (para-) pharmaceutical 
companies 
(Human) Organized  
sports world 
Staff members of sports teams  
Staff members of sporting federations 
Horseracing 
Veterinary physicians 
Breeders 
Drivers 
Use 
Athletes  
Law enforcement officers practicing as body-builders 
Other 
People with no distinctive profession or occupation  
(e.g., truck robbers) 
Many suppliers belong, or are close to, 
organized sports world 
• Pharmacists:  
– E.g., Dr. Nigrelli 
• Physicians:  
– E.g., Prof. Conconi, Dr. Ferrari and others 
• Staff members of sports teams:  
– E.g., staff members of cycling teams as well as manager and chief 
team physician of Juventus football club 
• Staff members of sports federations:   
– Dr. Faraggiana, FIDAL physician, and Camerini, FCI high-level 
official  involved in “Oil for Drug” 
• Veterinary physicians, breeders and horse riders 
• Athletes from different sports  
 
 
Many of them abuse position of authority and athletes’ trust 
Distribution chains are also semi-legal 
1. Doping methods 
– No separate distribution system 
2. Substances manufactured for doping purposes 
– In pharmacies or in illegal labs, in Italy or abroad 
• “Producers-retailers” or distribution chain 
– Internet plays increasingly important role in sale of substances 
produced in illegal labs  
3. Substances manufactured for legitimate purposes, in 
Italy or abroad, then diverted by 
– Manufacturers or distributors, their dependencies or employees 
– Traders, who sometimes sell drugs on the internet 
– Robbers stealing from trucks or deposits 
– Hospital or health clinic employees stealing from deposits 
– Pharmacists or their employees 
 
 
 
 
Users bypass domestic distribution by buying stuff on internet 
Methods 
Sale, transfer or administration  of doping substance or method 
 Money payment Possible money 
payment Substances manufactured for doping purposes  
Actor committing a crime 
Pharmacist Intermediat
e 
supplier(s) 
User 
Substances manufactured for legitimate purposes by pharmaceutical companies 
Physician  
or other 
Users 
Producer of 
raw materials 
Distributor(s) 
Illegal lab 
Intermediate 
supplier(s) 
User Producer of 
raw materials 
Distributor(s) 
Trader Intermediate 
supplier(s) 
User 
Pharmaceutic
al company Distributor(s) 
Intermediate 
supplier(s) User 
Pharmaceutic
al company 
Distributor(s)/ 
transporter Truck robber 
Thief (hospital 
employee) 
Intermediate 
supplier(s) User 
Pharmaceutica
l company 
Distributor(s)/ 
transporter 
Hospital 
Intermediate 
supplier(s) User 
Pharmaceutical 
company 
Distributor(s)/ 
transporter Pharmacist 
Physician 
Intermediate 
supplier(s) User 
Pharmaceutical 
company 
Distributor(s)/ 
transporter Pharmacist 
Physician 
1. 
Legend:  
2a. 
2b. 
Actor unaware of committing a crime 
Possible actor 
3a. 
3b. 
3c. 
3d. 
3e. 
Actor may or may not 
commit a crime 
Central server  
SLOVENIJA 
WEB SITES 
COUNTRY A 
WEB SITES 
COUNTRY B 
WEB SITES 
COUNTRY F 
WEB SITES 
COUNTRY C 
WEB SITES 
COUNTRY D 
WEB SITES 
COUNTRY E 
STORAGE  
SHIPPING 
STORAGE  
SHIPPING 
Update stock 
    (replace sold goods) 
Orders 
China 
Thailand 
Eastern Europe 
S
up
pl
y 
go
od
s 
P
ay
m
en
t 
SEVERAL BANKS  
COUNTRY X 
Pay suppliers 
Pay shippers 
Other expenses 
Net profit 
Protection of national sports bodies  
is startling peculiarity of doping market 
• Officials and staff members of sports bodies were openly 
accomplices of doping elite athletes until 1990s 
– Three CONI Presidents charged of criminal organization with Prof. 
Conconi for administering dangerous drugs to super elite athletes 
– IOC-accredited anti-doping lab in Rome closed in 1998 because it 
did not test football players for steroids 
– Reports of doping practices were covered up  by sport body officials  
• Since 2000 lack of commitment in anti-doping and seeming 
tolerance of elite athletes’ doping practices 
Unparalleled case of government-tolerated and funded (!) 
system of illegality 
A case of organized crime? 
• Most suppliers are white-collar criminals 
• Very limited mafia involvement 
– Only Neapolitan camorra groups are involved in two side-activities 
• “Receive” drugs stolen by truck robbers 
• Engage in fixing horse races in Naples area by administering doping 
substances to horses 
• No evidence of bribery or explicit violence 
• Yet, if EU definition of organized crime is accepted, both 
suppliers and trade can be seen as organized crime  
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Low (official) prices per dose 
Type of substance 
Active 
ingredients of 
one dose 
Average 
price/dose 
Anabolic agents (including 
testosterone) 
10 mg 1.12 
Peptide hormones, growth factors and 
related substances,* of which: 
Variable 4.76 
- EPO and other similar hormones  200 IU or 1 mcg 3.09 
- GH and other similar hormones 1 IU or 0.333 mg 13.90 
- Related substances**, of which Variable 2.50 
*Chorionic gonadotrophin 1,000 IU 3.27 
*Gonadorelin 1.2 mg 48.05 
*ACTH and other  corticotrophins 0.25 mg 3.70 
*Insulin 10 IU 0.03 
Beta-2 agonists 2 mcg 0.20 
Hormones and metabolic modulators 10 mg 1.26 
Diuretics and other masking agents 25 mg 0.40 
Stimulants 25 mg 0.60 
Narcotics 50 mg 1.28 
Glucocorticosteroids 25 mg 0.49 
Beta-blockers 5 mg 0.26 
Source: Our calculations on the basis of the Database on NAS 
investigations. 
• Official prices are cheaper 
than those of illegal drugs  
• Exceptions are GH and 
gonadorelin 
• By comparison, 0.25 gram 
doses of heroin and cocaine 
cost €10.49 and €17.29 and 
a hashish joint €3.73 
• But, prices paid by users 
may differ greatly from 
official price 
 
Relatively modest revenues and profits 
• By multiplying official prices per dose with estimate of doses 
consumed, we estimate yearly revenues of €537 million 
– Smaller than illegal drugs (e.g., cocaine revenues ca. €3,685 million) 
– Estimate is very conservative, as it reflects limits of testing and 
excludes GH and gonadorelin 
• No information on manufacturers’ revenues and profits, as 
only one lab has been seized in Italy 
• Most other suppliers do not earn much 
– Few physicians (e.g.,Ferrari) serving elite athletes constitute 
exception 
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Legislation: Act 376/2000 is key  
but other offences are also relevant 
• Act 376/2000 is cornerstone of Italy’s anti-doping policy 
– Establishes three offences of anti-doping 
• First two concern athletes and their support personnel for procuring, 
administering, assuming or even encouraging the use of doping 
substances or methods, to improve an athlete’s performance or to 
modify test (art. 9, §§ 1 and 2)  
• The third tackles illegal suppliers trading in doping substances outside  
official distribution channels (art. 9, § 7)  
– Sets up CVD 
• Other offences are also charged in investigations, e.g.: 
– Several offences of criminal code  
– Sporting fraud (art. 1 of Act 401/1989) 
– Other offences from drug law, customs law and law implementing 
European Directive 2001/83/CE on Human medicines 
NAS carries out bulk  
of anti-doping investigations 
• NAS is specialized unit of Carabinieri, its main mission is 
health protection 
– 3,794 suspects reported for doping and 446 arrested in 2001-2010  
– Invest about 14% of their resources in doping 
– Direct personnel costs for anti-doping are €1.4 million 
• Other law enforcement agencies occasionally seize doping 
substances and carry out investigations 
• Prosecutors are fully independent on executive, few very 
resolute and have launched high-level investigations 
– Negative side-effects: lack of prioritization and coordination, 
dependence on single prosecutor’s good will and competence 
 
Outcomes: Significant number  
of cases initiated and persons charged … 
  Section 1 Section 7 Total 
  Cases 
Persons 
charged 
Cases 
Persons 
charged 
Cases 
Persons 
charged 
2001 1   0   1   
2002 3   1   4   
2003 9   9   18   
2004 14   8   22   
2005 10   15   25   
2006 31 76 42 156 73 232 
2007 19 40 34 116 53 156 
2008 27 73 22 44 49 117 
2009 36 64 32 114 68 178 
Total 2001-09 150 n.a. 163 n.a. 313 n.a. 
Average 2001-09 17 n.a. 18 n.a. 35 n.a. 
Total 2006--09 113 253 130 430 243 683 
Average 2006-09 28 63 33 108 61 171 
Source: our elaboration on Istat, 2012. 
• Among the persons charged, there are high-level athletes, 
support personnel and other suppliers 
Outcomes: … but very few  
criminal convictions 
• No exact statistics but few final verdicts are known 
– Some verdicts involved high-level athletes 
• Three explanations: 
– Many proceedings are still ongoing, most started after 2003 
– They often end with a patteggiamento (bargaining agreement) 
– Statute of limitations expires on many proceedings 
• Criminal investigations provides evidence for successful 
disciplinary proceedings under sports rules 
– According to Haas, 90% of the cases he reviews at CAS concerning 
support personnel comes from Italy 
• Some prosecutors hesitate to share data with CONI due to 
mistrust 
Five challenges hamper  
anti-doping criminal action 
• General inefficiency of Italian criminal justice system is 
major obstruction 
• Four are domestic: 
– Specific aspects of Act 376/2000 
– Prosecutors and judges’ insufficient knowledge of doping and anti-
doping legislation, need to rely on external experts 
– Limited cooperation between law enforcement agencies and 
sports authorities 
– CVD’s deficient coordination of Italy’s anti-doping policy 
• Fifth challenge concerns difficulties in international police 
and judicial cooperation 
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Lessons for policy-making - Market 
• Elite athletes targeted by CONI, sports federations and 
WADA constitute tiny minority of users 
 Policy focus must be broadened to include recreational users 
• In other countries too, demand is met by semi-legal supply 
 There is a need to know more  
• Users can obtain doping products from multiple sources, 
often through internet 
 No doping-free world is possible, no “war on doping” makes sense  
• White-collar crime nature of supply is opportunity for 
controlling doping  
 Use all means of Braithwaite’s “regulatory pyramid” 
• Organized sports world cannot be trusted with anti-doping 
and its means (testing) are insufficient  
 National governments need to intervene directly  
 
Braithwaite’s regulatory pyramid  
and its underlying philosophies 
Lessons for policy-making - Enforcement 
• Prosecution of key figures, under criminal law or sports rules, 
can play relevant symbolic and educational functions  
 Make criminal investigations possible in all countries  
• Criminal investigations can better shed light on supply and are 
cheaper and “fairer” than testing 
 Complement testing with criminal investigations  
• Better serve public health perspective  
 Give up exclusive focus on elite sports 
• Are hampered by lack of harmonized legislation 
 Harmonize national legislations, exploit equivalent offences  
• Depend on law enforcement’s specialized knowledge 
 Create special units, train personnel, involve (NADO) experts 
 
 
Lessons for policy making - General 
• Many relevant pieces of information on demand, supply 
and policy outcomes are still unknown 
 Develop national and international monitoring system(s), 
exploiting existing networks (e.g., EMCDDA, UNODC), e.g., 
̶ on the supply:  
• Amounts of doping substances seized in standardized units  
• Share of counterfeited products out of those seized and sold 
• Wholesale and retail prices of different substances 
• Share of worldwide production of some key drugs misused for doping purposes  
• New substances entering the market 
̶ on anti-doping criminal law enforcement:  
• Doping-related criminal offenses and sanctions foreseen 
• Number of criminal proceedings initiated and their outcomes (e.g., reports, 
suspects, defendants, case law and sanctions)   
 
